Final version of the Swiss TARDOC reimbursement system for outpatient care re-submitted for approval

10

Jan 2022

On December 20, 2021, the tariff partners of the novel TARDOC reimbursement system for outpatient care (association of health insurers curafutura and association of physicians, FMH) re-submitted the substantially revised version 1.3 of TARDOC to the Federal Council. The new version entails an extension of cost neutrality, a simplification of tariffs, and an increase in transparency. Previously, the tariff partners submitted the TARDOC reimbursement system to the Federal Council in early 2021, but the Federal Council found the TARDOC tariff structure to have many drawbacks and that it would not guarantee cost neutrality.

The two tariff partners not involved so far, the association of hospitals (H+) and another association of health insurers (santésuisse), also actively participated in the revision of the TARDOC this time, as requested by the Federal Council.

The tariff partners hope that the Federal Council will assess the new reimbursement system in the first quarter of 2022 and that it could be implemented from January 2023.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more